Holen Sie sich die Stockscreener-App
104.08
1.33%
-1.40
Handel nachbörslich:
104.08
Schlusskurs vom Vortag:
$105.48
Offen:
$106.72
24-Stunden-Volumen:
559.04K
Relative Volume:
3.58
Marktkapitalisierung:
$575.03M
Einnahmen:
$249.13M
Nettoeinkommen (Verlust:
$6.71M
KGV:
86.19
EPS:
1.2076
Netto-Cashflow:
$39.58M
1W Leistung:
-4.04%
1M Leistung:
+7.89%
6M Leistung:
+33.73%
1J Leistung:
+7.19%
1-Tages-Spanne:
$101.79
$107.79
1-Wochen-Bereich:
$101.79
$113.99
52-Wochen-Spanne:
$55.45
$113.99
Mesa Laboratories Inc Stock (MLAB) Company Profile
Firmenname
Mesa Laboratories Inc
Sektor
Telefon
(303) 987-8000
Adresse
12100 W 6TH AVE, LAKEWOOD
Compare MLAB vs COHR, KEYS, GRMN, TDY, MKSI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MLAB
Mesa Laboratories Inc
|
104.08 | 582.77M | 249.13M | 6.71M | 39.58M | 1.2076 |
COHR
Coherent Corp
|
413.84 | 75.33B | 6.60B | 452.58M | -538.24M | 2.0946 |
KEYS
Keysight Technologies Inc
|
356.94 | 59.93B | 6.09B | 1.07B | 1.36B | 6.0693 |
GRMN
Garmin Ltd
|
238.17 | 45.92B | 7.46B | 1.74B | 1.45B | 8.9685 |
TDY
Teledyne Technologies Inc
|
628.34 | 29.00B | 6.22B | 933.70M | 1.05B | 19.76 |
MKSI
Mks Inc
|
375.32 | 24.02B | 4.07B | 328.00M | 380.00M | 4.7842 |
Mesa Laboratories Inc Stock (MLAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-07 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-10-02 | Eingeleitet | JP Morgan | Neutral |
| 2019-12-04 | Eingeleitet | Jefferies | Buy |
| 2019-08-26 | Eingeleitet | Evercore ISI | Outperform |
| 2016-06-10 | Herabstufung | Sidoti | Buy → Neutral |
Alle ansehen
Mesa Laboratories Inc Aktie (MLAB) Neueste Nachrichten
MLAB Q1 2026 Earnings: EPS Misses Estimates by Significant Margin, Stock DeclinesRevenue Breakdown Analysis - newsline.com
Mesa Laboratories (MLAB) Sees Modest Gains Amid Consolidation Above Key SupportWedge Breakout - newsline.com
MLAB Q1 2026 Earnings: Significant EPS Miss Amid Negative SurpriseFinancial Data - newsline.com
Mesa Laboratories Stock Slides 4.8%: Key Support Level in FocusHull Moving Average - newsline.com
3 Stocks Estimated To Be Trading 16.4% To 42% Below Intrinsic Value - simplywall.st
MLAB Q1 2026 Earnings: Significant EPS Miss Amidst Operational ChallengesEarnings Whisper Number - newsline.com
Mesa Laboratories Inc. (MLAB) Declines 4.19% as Shares Test Key Support LevelsSector ETF Flow - newsline.com
Mesa Laboratories : Annual Report for Fiscal Year Ending 03-31, 2026 (Form 10-K) - marketscreener.com
Mesa Laboratories, Inc. 2026 Annual Report: Business Overview, Strategy, Segments, and Key Risk Factors - Minichart
Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005. - marketscreener.com
Mesa Laboratories (NASDAQ: MLAB) outlines global segments, GKE deal and key risks - Stock Titan
MLAB Q1 2026 Earnings: EPS Soars Past Estimates by 695%, Revenue Data UnavailableProfit Guidance Range - The Legal Advocate
Mesa Laboratories (MLAB) Slips 1.05% as Stock Nears Support ZoneStock Buy Zone - The Legal Advocate
Jefferies raises Mesa Laboratories stock price target on CEO outlook By Investing.com - Investing.com Nigeria
Jefferies raises Mesa Laboratories stock price target on CEO outlook - Investing.com
Mesa Labs 4Q Rev $63.7M >MLAB - Moomoo
Mesa Labs 4Q Loss $4.14M >MLAB - Moomoo
Mesa Labs earnings beat by $1.76, revenue fell short of estimates - Investing.com Canada
Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today - The Motley Fool
Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today - The Motley Fool
Mesa Laboratories' Stock Slips as 4Q Growth Misses Targets - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Mesa Labs 4Q Loss/Shr 75c >MLAB - Moomoo
Is Mesa Laboratories (MLAB) Modestly Undervalued Despite Q4 FY26 - GuruFocus
Mesa Laboratories Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Press Release: Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results - Moomoo
MESA LABORATORIES ($MLAB) Releases Q4 2026 Earnings - Quiver Quantitative
Mesa Labs: Fiscal Q4 Earnings Snapshot - marketscreener.com
Mesa Laboratories reports FY26 revenue $249.1M, operating income $18.5M, AOI ex-unusual $63.5M - TradingView
Mesa Laboratories (NASDAQ: MLAB) grows FY26 revenue 3.4% as margins expand - Stock Titan
Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results - GlobeNewswire
Mesa Laboratories Inc. (MLAB) Q1 2026 Earnings: Strong EPS Surprise of 130% Amid Quiet Revenue DisclosureEPS Miss Report - The Legal Advocate
MLAB Q1 2026 Earnings: Significant EPS Beat Driven by Strong Operational PerformanceRevenue Warning Signal - The Legal Advocate
MLAB Q1 2026 Earnings: Earnings Per Share Surges Past Estimates by Over 130%High Growth Earnings - newsline.com
Mesa Laboratories Inc. (MLAB) Q1 2026 Earnings: Stellar EPS Surprise of 130% Drives Optimism Amidst Quiet Revenue PeriodRevenue Growth Report - Newser
MLAB Q1 2026 Earnings: EPS Surges 130% Above Estimates Amid Operational Efficiency GainsRevenue Inflection Point - newsline.com
Mesa Labs Stock Pops Before the Date Investors Can’t Ignore - Bez Kabli
MLAB Q4'25 Earnings: revenue estimate is 65.21M USD - TradingView
Mesa Laboratories (MLAB) CEO awarded 35,236 restricted stock units in Form 4/A - Stock Titan
Mesa Laboratories stock (US59064R1095): Precision tools for life sciences - AD HOC NEWS
MLAB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MLAB Mesa Laboratories posts 130% earnings beat, but MLAB shares fall 1.39% despite strong 11.5% revenue growth.Shared Momentum Picks - Newser
Mesa Laboratories Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026 - Weekly Voice
Mesa Laboratories, Inc. Scheduled to Release Q4 and Fiscal Year 2026 Financial Results on May 27, 2026 - Quiver Quantitative
Mesa Labs sets May 27 release for full-year and Q4 results - Stock Titan
Mesa Laboratories names new CEO - MSN
Long Path Partners LP's Mesa Laboratories Inc(MLAB) Holding History - GuruFocus
Is Mesa Laboratories (MLAB) stock overvalued after recent rally (+1.09%) 2026-04-27Institutional Flow Picks - newsline.com
Finanzdaten der Mesa Laboratories Inc-Aktie (MLAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.94%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):